bioAffinity Technologies, Inc. Common Stock vs. OmniAb, Inc. Common Stock
BIAF
bioAffinity Technologies, Inc. Common Stock
$10.45 +58.60%
VS OABIOmniAb, Inc. Common Stock
$5.14 +15.88%
bioAffinity Technologies, Inc. Common Stock and OmniAb, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BIAF | OABI | |
|---|---|---|
| Market Cap | $3.90 million | $645.53 million |
| Revenue (TTM) | $5.90 million | — |
| Net Income (TTM) | $-15,185,242 | — |
OABI leads on 1 of 1 size & scale factors.
Valuation
| BIAF | OABI | |
|---|---|---|
| Price / Book | 1.04 | — |
| Price / Sales | 0.66 | — |
BIAF and OABI split the valuation factors evenly.
Profitability
| BIAF | OABI | |
|---|---|---|
| Net Margin | -257.33% | — |
| Return on Equity | -402.92% | — |
BIAF and OABI split the profitability factors evenly.
Risk & Sentiment
| BIAF | OABI | |
|---|---|---|
| Short Interest | 1.46% | 1.67% |
BIAF leads on 1 of 1 risk & sentiment factors.
Dig deeper: BIAF overview, BIAF financials, OABI overview, OABI financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.